Carol A. Ziomek, PhD is vice president for development at GTC Biotherapeutics, Inc.
Production of Recombinant Therapeutic Proteins in the Milk of Transgenic Animals
Capital investments in production plants represent a significant portion of the cost of new recombinant drugs